Alissa A. Thomas

803 total citations
35 papers, 514 citations indexed

About

Alissa A. Thomas is a scholar working on Genetics, Neurology and Oncology. According to data from OpenAlex, Alissa A. Thomas has authored 35 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 12 papers in Neurology and 9 papers in Oncology. Recurrent topics in Alissa A. Thomas's work include Glioma Diagnosis and Treatment (18 papers), Brain Metastases and Treatment (8 papers) and Palliative Care and End-of-Life Issues (5 papers). Alissa A. Thomas is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), Brain Metastases and Treatment (8 papers) and Palliative Care and End-of-Life Issues (5 papers). Alissa A. Thomas collaborates with scholars based in United States, Canada and United Kingdom. Alissa A. Thomas's co-authors include Antonio Omuro, Lisa M. DeAngelis, Cameron Brennan, Joseph H. Friedman, Melissa M. Amick, Camilo E. Fadul, Noah Kolb, Waqar Waheed, Marc S. Ernstoff and Jan L. Fisher and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Alissa A. Thomas

30 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alissa A. Thomas United States	11	168	139	138	97	88	35	514
Uğur Sener United States	13	214 1.3×	153 1.1×	83 0.6×	170 1.8×	91 1.0×	68	665
Cristina Prieto Spain	12	43 0.3×	56 0.4×	36 0.3×	210 2.2×	44 0.5×	21	423
Maximilian J. Mair Austria	14	201 1.2×	211 1.5×	75 0.5×	79 0.8×	76 0.9×	45	539
Meghan E. Munger United States	9	86 0.5×	577 4.2×	96 0.7×	171 1.8×	794 9.0×	20	1.2k
Susan D. Bell United States	8	264 1.6×	180 1.3×	131 0.9×	140 1.4×	86 1.0×	17	561
Henry Ruiz-García United States	14	249 1.5×	112 0.8×	95 0.7×	89 0.9×	41 0.5×	38	552
Laurèl Rauschenbach Germany	14	155 0.9×	47 0.3×	290 2.1×	70 0.7×	34 0.4×	79	540
Carole Ramirez France	9	203 1.2×	217 1.6×	73 0.5×	272 2.8×	103 1.2×	23	704
Brittany Voth United States	13	133 0.8×	59 0.4×	96 0.7×	107 1.1×	30 0.3×	29	508
Barbara O’Brien United States	14	239 1.4×	180 1.3×	38 0.3×	108 1.1×	54 0.6×	56	478

Countries citing papers authored by Alissa A. Thomas

Since Specialization

Citations

This map shows the geographic impact of Alissa A. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alissa A. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alissa A. Thomas more than expected).

Fields of papers citing papers by Alissa A. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alissa A. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alissa A. Thomas. The network helps show where Alissa A. Thomas may publish in the future.

Co-authorship network of co-authors of Alissa A. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Alissa A. Thomas. A scholar is included among the top collaborators of Alissa A. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alissa A. Thomas. Alissa A. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Callas, Peter, et al.. (2025). Single-center retrospective analysis of the impact of rurality on glioblastoma care in Vermont. BMC Health Services Research. 25(1). 1052–1052.

Dewitt, John M., et al.. (2024). Rare dual‐genotype IDH mutant glioma: Review of previously reported cases and two new cases of true “oligoastrocytoma”. Neuropathology. 44(5). 401–407. 1 indexed citations

Fadul, Camilo E., Joseph Bovi, Alissa A. Thomas, et al.. (2023). Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain Metastases. Cancers. 15(12). 3255–3255. 5 indexed citations

Polácek, L, Katherine S. Panageas, Anne S. Reiner, et al.. (2022). Coping with glioblastoma: prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologists. Journal of Neuro-Oncology. 158(1). 69–79. 9 indexed citations

Anderson, Collin J., et al.. (2021). Case Report of Lambert Eaton Myasthenic Syndrome in a Patient with Small Cell Lung Cancer on Immune Checkpoint Inhibitor Therapy. OBM Neurobiology. 5(1).

Thomas, Alissa A., et al.. (2021). Safety of apixaban for venous thromboembolic primary prophylaxis in patients with newly diagnosed malignant glioma. Journal of Thrombosis and Thrombolysis. 53(2). 479–484. 7 indexed citations

Thomas, Alissa A., et al.. (2020). Experience and Attitudes Regarding Medical Aid in Dying, Act 39, among Vermont Primary Care Physicians: A Call for More Education and Resources. Journal of Palliative Medicine. 24(1). 5–6. 1 indexed citations

Thomas, Alissa A., et al.. (2020). Benign and malignant tumors of the central nervous system and pregnancy. Handbook of clinical neurology. 172. 241–258. 4 indexed citations

Thomas, Alissa A., et al.. (2020). Neurological Complications of CAR T Cell Therapy. Current Oncology Reports. 22(8). 83–83. 19 indexed citations

10.

Thomas, Alissa A., et al.. (2019). Experience and Attitudes Regarding Medical Aid in Dying, Act 39, among Vermont Specialty Practices. Journal of Palliative Medicine. 23(3). 375–378. 5 indexed citations

11.

DeWitt, John, et al.. (2019). Disseminated Rosette-Forming Glioneuronal Tumor with Spinal Drop Metastasis, a Uniquely Aggressive Presentation of Rare Tumor. World Neurosurgery. 132. 7–11. 8 indexed citations

12.

Thomas, Alissa A., Marc K. Rosenblum, Sasan Karimi, et al.. (2018). Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab. CNS Oncology. 7(1). 7–13. 4 indexed citations

13.

Thomas, Alissa A., et al.. (2017). RARE-30. ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA WITH LEPTOMENINGEAL DISSEMINATION RESPONSIVE TO BRAF INHIBITION AND BEVACIZUMAB. Neuro-Oncology. 19(suppl_6). vi216–vi216. 2 indexed citations

14.

Thomas, Alissa A., Jan L. Fisher, Thomas H. Hampton, et al.. (2016). Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma. Cancer Immunology Immunotherapy. 66(3). 379–389. 20 indexed citations

15.

Thomas, Alissa A. & Alan Carver. (2015). Essential competencies in palliative medicine for neuro-oncologists. Neuro-Oncology Practice. 2(3). 151–157. 4 indexed citations

16.

Thomas, Alissa A., James L. Fisher, Gilbert J. Rahme, et al.. (2015). Regulatory T cells are not a strong predictor of survival for patients with glioblastoma. Neuro-Oncology. 17(6). 801–809. 46 indexed citations

17.

Thomas, Alissa A. & Antonio Omuro. (2014). Current Role of Anti-Angiogenic Strategies for Glioblastoma. Current Treatment Options in Oncology. 15(4). 551–566. 22 indexed citations

18.

Thomas, Alissa A., Cameron Brennan, Lisa M. DeAngelis, & Antonio Omuro. (2014). Emerging Therapies for Glioblastoma. JAMA Neurology. 71(11). 1437–1437. 139 indexed citations

19.

Thomas, Alissa A., et al.. (2013). Anti–N-Methyl-d-Aspartate Receptor Encephalitis. JAMA Neurology. 70(12). 1566–8. 26 indexed citations

20.

Thomas, Alissa A., et al.. (2010). Falls and the falls efficacy scale in Parkinson’s disease. Journal of Neurology. 257(7). 1124–1128. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact